Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited on...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Babić, Mirjana, Švob Štrac, Dubravka, Mück-Šeler, Dorotea, Pivac, Nela, Stanić, Gabrijela, Hof, Patrick R., Šimić, Goran
Médium: Artigo
Jazyk:Inglês
Vydáno: Croatian Medical Schools 2014
Témata:
Cerebrospinal Fluid Physiology and Movement
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157375/
https://ncbi.nlm.nih.gov/pubmed/25165049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2014.55.347
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky